RxDoctor Payments Data

Troy Hemme, DO

Otolaryngology · Maple Grove, MNNPI 1831406040

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (33.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 87.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $16,623 and has fallen 97.8% since, to $361 in 2025. Among otolaryngology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,583in general payments, 2019–2025

Across 123 payments — averaging $224.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$24K
  • Acclarent, Inc$1K
  • Integra Lifesciences Corporation$478
  • Medical Device Business Services, Inc.$422
  • Medtronic$228
  • Intersect ENT, Inc.$221
  • plus $561 from 11 others

What the payments were for

  • Consulting fees$9,10033%
  • Speaking & faculty fees$8,48831%
  • Travel & lodging$6,12222%
  • Food & beverage$3,87414%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,583 in reported general payments places this provider in the 95th percentile of 181 otolaryngology providers in Minnesota.

See all otolaryngology providers in Minnesota

Medicare billing

Part B allowed, 2024
$88,809
Medicare patients
269
Services billed
671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$48,225
Ipratropium Bromide183$5,205
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth35$4,469
Fluticasone Propionate99$1,444
Fluocinolone Acetonide Oil21$637
Azelastine Hcl19$400
Mupirocin43$325
Methylprednisolone49$318
Doxycycline Monohydrate22$315
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$291
CefuroximeCefuroxime Axetil13$223
Omeprazole21$203
Prednisone16$149
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$94

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Maple Grove

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →